|
|
|
|
Sarcomas
Skeletons in the p53 tumor suppressor closet: genetic evidence ... 14 Mar 2006
Journal of Cell Biology A substantial percentage of human soft tissue sarcomas and other tumor types harbor wild-type p53 alleles that are inactive because of the amplification and ...
Cytogenetics Help Predict Outcomes of Soft Tissue Sarcomas Mar 7, 2006
Cancer Consultants (press release), Researchers from Sweden have reported that cytogenetic examination of soft tissue sarcomas (STS) helps predict the development of metastatic disease in adult ...
Neoadjuvant Chemotherapy and Radiotherapy Promising for Large Soft ... Mar 3, 2006
Cancer Consultants (press release), Phase II study of neoadjuvant chemotherapy and radiation therapy in the management of high-risk, soft tissue sarcomas of the extremities and body wall ...
Oncologists say war on cancer is being won Mar 9, 2006
WALB-TV, ...speak. They are renowned for their expertise in Sarcomas, a rare form of soft tissue cancer. Dr. Terry Kraus said, "The University ...
Young cancer patients unique Mar 12, 2006
ChronicleHerald.ca, ...has seen 19- and 21-year-old women with breast and colon cancer, usually found in older adults, and people in their late teens with sarcomas most common in ...
ARIAD Initiates First Clinical Trial of Oral AP23573 in ... Feb 14, 2006
Genetic Engineering News, In particular, doxorubicin is widely used in soft-tissue and bone sarcomas, as well as breast, ovarian and endometrial cancers - all potential targets for ...
PET/CT with Diagnostic CT in the Evaluation of Childhood Sarcoma Feb 14, 2006
Am J Roentgenology (subscription) We would like to add our own experience with more than 150 pediatric patients with various malignancies, including 67 patients with sarcomas: Our experience [2 ...
Hotline to focus on marrow problems Mar 9, 2006
Deseret News, ...stem cell or bone marrow transplant may cure a variety of cancers, including leukemia, lymphoma, multiple myeloma and certain solid tumors such as sarcomas. ...
On the road again Mar 9, 2006
Joplin Globe, My biggest fear has been that the chemo might not be working. I had been warned that with sarcomas, chemotherapy doesn't always do the job.Well, you know what? ...
Avastin® Adriamycin Combination for Soft Tissue Sarcoma Mar 8, 2006
Cancer Consultants (press release), Twelve had received prior surgery. Eleven of the patients had leiomyosarcomas and the remaining being single patients with other types of specific sarcomas. ...
Ariad Initiates Trial of Anticancer Candidate Feb 15, 2006
International News Service, In particular, doxorubicin is widely used in soft-tissue and bone sarcomas, as well as breast, ovarian and endometrial cancers - all potential targets for ...
Sandwich study: Why and how? Feb 11, 2006
Cape Cod Times, ...diagnosed with leukemia, three children were diagnosed with a central nervous system tumor, two children were diagnosed with soft tissue sarcomas, one child ...
Point Therapeutics Announces Collaboration with the National ... Feb 14, 2006
Genetic Engineering News, Sarcomas are cancerous tumors of the bone or soft tissues and comprise approximately 7% of all cancers in children age 20 years or younger. ...
Neoadjuvant Sarcoma Chemotherapy Results in High Toxicity Levels Mar 1, 2006
Cancerpage.com, NEW YORK FEB 28, 2006 (Reuters Health) - Combined-modality treatment of high-risk, high-grade soft tissue sarcomas of the extremity and body wall leads to ...
Functional Results and Quality of Life After Treatment of Pelvic ... Mar 1, 2006
Journal of Bone and Joint Surgery C. Hoffmann, MD 1 , G. Gosheger, MD 1 , C. Gebert, MD 1 , H. Jürgens, MD 1 and W. Winkelmann, MD 1. 1 Departments of Orthopedics ...
Fumigant Could Pose Health Risk Feb 20, 2006
Los Angeles Times, ...was injected into rats, not inhaled. The rats developed sarcomas that spread to their lungs. The EPA's analysis focused instead ...
ARIAD To Participate in Focus Session on New Cancer Treatments at ... Feb 13, 2006
Genetic Engineering News, ...an orphan drug by the US Food and Drug Administration and as an orphan drug by the European Medicines Agency for the treatment of soft tissue and bone sarcomas ...
Carolina Regional Cancer Center announces clinical affiliation ... Feb 16, 2006
Carolina Newswire (press release), Stephen R. Andrews, DO, has been published for his research on prostate cancer and soft tissue sarcomas. He also has a particular interest in breast cancer. ...
Anthracyclines Linked with Damage to Blood Vessels Feb 24, 2006
Cancer Consultants (press release), These drugs, which include doxorubicin and daunorubicin, are used to treat a variety of cancers, including Hodgkin’s lymphoma, sarcomas, and breast cancer. ...
Save our children from pesticides 25 Jan 2006
Cayman Net News, ...studies indicate an association between pesticide exposure and the development of certain cancers in children, including leukemia, sarcomas and brain tumours. ...
Alicia's Story Jan 23, 2006
San Francisco Chronicle, Sarcomas are a class of rare cancers comprising about 1 percent of new adult cases; they are more common in children. Specific types ...
Cancer vocab Jan 21, 2006
Malaysia Star, ...breast. Most of the cancers are carcinomas. Some cancers that arise from connective tissues like bone are called sarcomas. Cancer ...
Douglas High School student battles tumor, disease, state Jan 22, 2006
The Record-Courier, James has rhabdomyosarcoma, a fast-growing, highly malignant tumor that accounts for over half of the soft tissue sarcomas in children, according to ...
The day the sky fell in Jan 15, 2006
Sydney Morning Herald, Laurie returned home, while the doctors pronounced that surgery - the normal strategy for sarcomas - was impossible because of the site of the tumour, and that ...
A War's Unwelcome Vestiges Jan 17, 2006
TheDay (subscription), ...is on the VA's list, as is chronic lymphocytic leukemia, multiple myeloma, Hodgkin's disease, respiratory cancers, prostate cancer, soft-tissue sarcomas and a ...
The index of successful treatment of children with cancer tops 75% Jan 3, 2006
Basque Research.com, ...in pediatric cancer with respect to adult cancer, with some types of cancers being more frequent: certain types of leukemia and lymphoma, sarcomas, and a ...
Europe: European stocks rise as dollar strengthens 21 Dec 2005
International Herald Tribune, It said it would not file for approval for its Yondelis treatment for soft-tissue sarcomas by year's end, missing its own goal, as it and partner Johnson & ...
PharmaMar Confirms Intention to Submit MAA Dec 19, 2005
APA OTS (Pressemitteilung), ...with Johnson & Johnson Pharmaceutical Research & Development) in Phase III clinical trials; it is designated Orphan Drug for soft tissue sarcomas and ovarian ...
Stem cells may cause some forms of bone cancer Dec 6, 2005
News-Medical.net, ..."The existence of stem-like cells in bone sarcomas suggests that ... It makes sense that bone sarcomas occur in anatomic areas containing stimulated stem cells. ...
Twenty-Seven Percent Of Advanced Sarcoma Patients Experience ... Nov 18, 2005
DG News PHILADELPHIA, PA -- November 18, 2005 -- A non-prodrug rapamycin analog is showing promising results in patients with refractory sarcomas, researchers from ...
New Cancer Treatment System by BSD Medical Acquired to Pioneer ... Dec 13, 2005
PR Newswire (press release), ...comparing the results of dual treatments with chemotherapy and the BSD-2000 system versus chemotherapy alone for patients with high-risk soft-tissue sarcomas. ...
Biking the Danish Islands for Awareness and a Cure Dec 6, 2005
PR Leap (press release), ...tired.�. The 100 cyclists in Denmark will be joined by hundreds of people around the world who will form local “Team Sarcomas�. ...
ARIMIDEX (anastrozole) Featured in Studies Evaluating Impact of ... Dec 9, 2005
PharmaLive.com (press release), In clinical trials, uterine cancers, including endometrial cancer and uterine sarcomas, and blood clots, including clots in the lungs, occurred 2 to 4 times ...
PharmaMar Reports Positive Phase II Results on Aplidin(R) in ... Dec 12, 2005
PR Newswire UK (press release), ...with Johnson & Johnson Pharmaceutical Research & Development) in Phase III clinical trials; it is also designated Orphan Drug for Soft Tissue Sarcomas and for ...
International Approvals: Procoralan, H101, AP2573 Nov 21, 2005
Medscape (subscription) ...the European Medicines Evaluation Agency has approved orphan drug status for a non-prodrug rapamycin analog in the treatment of soft-tissue and bone sarcomas. ...
Have a heavy Thanksgiving HAVE A HEAVY THANKSGIVING Nov 23, 2005
Kansas City Star, ...re-creation of a New York slum, so rooted in real-world grubbiness, that when a character dies of AIDS we get a glimpse of the sarcomas spreading across his ...
Deleted Genes Help Predict Outcome In A Children's Cancer Nov 24, 2005
Science Daily (press release) Its large basic and clinical research programs are particularly strong in pediatric neuro-oncology, neuroblastoma, leukemia and lymphoma, and sarcomas. ...
GlaxoSmithKline Presents Rapidly Expanding Pipeline of Oncology ... Nov 30, 2005
Finanzen.net, ...and prolonged stable disease was also observed in a number of other cancer types, including gastrointestinal, neuroendocrine, lung, thyroid and sarcomas. ...
'Rent' loses its lease Nov 24, 2005
The Olympian, ...recreation of a New York slum, so rooted in real-world grubbiness, that when a character dies of AIDS, we get a glimpse of the sarcomas spreading across his ...
NCI Announces Six Awards for the Strategic Partnering to Evaluate ... Nov 28, 2005
WebWire (press release), ...will refine and validate molecular signatures that provide a more accurate diagnosis and more accurately predict clinical behavior of common childhood sarcomas ...
Pediatric treatment helps young adults with cancer Nov 24, 2005
Palm Beach Post, Lauderdale. Cancers common in pediatrics — bone tumors, lymphomas, soft tissue sarcomas — can strike someone into their 20s. ...
Rate of Second Malignancies High After Treatment for Ewing Sarcoma Nov 23, 2005
Cancerpage.com, ...margins is feasible, even if it is not contraindicated by the patient's age or by the type of surgical reconstruction, because postirradiation sarcomas have a ...
Fever of Unknown Origin May Be a Marker for Undiagnosed Cancer Nov 23, 2005
Cancer Consultants (press release), Fever of unknown origin was most strongly associated with Hodgkin’s and non-Hodgkin’s lymphomas, sarcomas, leukemia, multiple myeloma, and cancers of the ...
UF researchers find key to childhood cancer Dec 5, 2005
Gainesville Sun, ..."The existence of stem-like cells in bone sarcomas suggests that the study of stem cell biology may provide opportunities for targeted therapies that are ...
Conference considers ultrasound for cancer treatment, noninvasive ... Nov 30, 2005
uwnews.org, ...four years of clinical use of high-intensity focused ultrasound for liver cancer, malignant bone tumors, breast cancer, soft tissue sarcomas, kidney cancer ...
Pediatric Cancer Foundation Launches Innovative Research Model in ... Nov 17, 2005
PR Newswire (press release), ...greater understanding of the disease, but have concluded that the pace of discovery for certain types of childhood cancer, particularly sarcomas, was far too ...
Soft-Tissue Sarcomas in Adults Aug 17, 2005
Soft-tissue sarcomas are uncommon tumors that have traditionally been managed by wide excisional surgery and radiotherapy; the use of chemotherapy has been ... New England Journal of Medicine (subscription),
FDA Approvals: Amplimexon, AP23573, TQ-1017 Sep 6, 2005
...orphan drug status for imexon for the treatment of ovarian cancer; a non-prodrug rapamycin analog for the treatment of soft-tissue and bone sarcomas; and an ... Medscape (subscription)
Hokies' Calloway battling tumor Sep 6, 2005
..."This one under the microscope is more like a cluster of grapes surrounded by blood supply. That structure makes it unique among all sarcomas. ... ... Roanoke Times,
Tech's Calloway battles cancer Sep 6, 2005
...rare tumor.". Said Doolan of alveolar soft part sarcoma: "It makes up about .2 to 1 percent of all sarcomas that are out there.". For ... Lynchburg News and Advance,
ARIAD Receives Orphan Drug Designations for AP23573 in the ... Aug 18, 2005
...inhibitor, has been designated an orphan drug by the United States Food and Drug Administration (FDA) for the treatment of both soft-tissue and bone sarcomas. ... Business Wire (press release),
Tech basketball player being treated for cancer Sep 6, 2005
...basketball trainer Keith Doolan said. "It makes up about .2 to 1 percent of all sarcomas that are out there.". Dr. Delmas Bolin, Tech's ... Richmond Times Dispatch,
Cancer-Causing Genes Can Convert Even the Most Committed Cells Aug 30, 2005
In human connective tissue cancers (called sarcomas), genetic exchange between Chromosomes 21 and 22 produces the EWS-ERG fusion gene; this translocation is ... RxPG NEWS,
Ariad gets orphan drug status for sarcoma drug Aug 18, 2005
Research) on Thursday said the US Food and Drug Administration awarded orphan drug status to its product for the treatment of soft-tissue and bone sarcomas. ... Reuters
Hot Stocks: JDSU LTD GNLB IDNX HOTT SNPS CRM RITA TINY -2 Aug 18, 2005
Said its novel mTOR inhibitor has been designated an orphan drug by the US Food and Drug Administration for the treatment of both soft-tissue and bone sarcomas ... Yahoo News
Highlights of rising and falling US stocks Aug 18, 2005
...its novel mTOR inhibitor, has been designated an orphan drug by the Food and Drug Administration for the treatment of both soft-tissue and bone sarcomas. ... Investor's Business Daily (subscription)
Ariad receives orphan drug designations Aug 18, 2005
...has had AP23573, its novel mTOR inhibitor, designated an orphan drug by the Food and Drug Administration for the treatment of both soft-tissue and bone sarcomas ... Boston Mass High Tech,
Ariad compound gains FDA 'orphan' status Aug 18, 2005
Nasdaq: ARIA) said Thursday that the FDA granted the special status for AP23573, a compound intended to treat soft-tissue and bone cancers known as sarcomas. ... Boston Business Journal,
Ariad raises $8.1M in stock sale Aug 19, 2005
...that it had gained "orphan drug" status from the US Food and Drug Administration for its potential treatment for soft-tissue and bone cancers known as sarcomas ... Boston Business Journal,
Powders of the Merchant Aug 24, 2005
...“Because sarcomas are a very rare tumor, and you have to understand that drug companies, pharmaceutical companies, have to report to their stockholders, and ... Cape Cod Today,
Ariad Compound Gains FDA 'orphan' Status and Myogen Shares Rise on ... Aug 19, 2005
Mass., company said Thursday that the FDA granted the special status for AP23573, a compound intended to treat soft-tissue and bone cancers known as sarcomas. ... Financial News USA (press release),
10 Things Your Veterinarian Won't Tell You Aug 16, 2005
Goldstein, a veterinarian in South Salem, NY, says he sees a range of vaccination-related reactions in animals, everything from cancerous sarcomas to epilepsy. ... Smartmoney.com (subscription)
Health Stocks in Motion Aug 18, 2005
...by the FDA. The inhibitor, designated as AP23573, is used for the treatment of both soft-tissue and bone sarcomas. AP23573, a small ... TheStreet.com
ALICIA'S STORY Aug 17, 2005
...www.sarcomaalliance.org. Sarcoma Foundation of America An advocacy group for increased research on treating and curing sarcomas. www.curesarcoma.org. ... San Francisco Chronicle,
Soft-Tissue Sarcomas in Adults -- Aug 17, 2005
Soft-tissue sarcomas are uncommon tumors that have traditionally been managed by wide excisional surgery and radiotherapy; the use of chemotherapy has been ... / New England Journal of Medicine (subscription),
Aplidin(R) Commences Combination Trials -- Sep 14, 2005
...with Johnson & Johnson Pharmaceutical Research & Development) in Phase III clinical trials; it is also designated Orphan Drug for Soft Tissue Sarcomas by the ... / APA OTS (Pressemitteilung),
ARIAD Receives Orphan Drug Designations for AP23573 in the ... -- Aug 18, 2005
...inhibitor, has been designated an orphan drug by the United States Food and Drug Administration (FDA) for the treatment of both soft-tissue and bone sarcomas. ... / Business Wire (press release),
FDA Approvals: Amplimexon, AP23573, TQ-1017 -- Sep 6, 2005
...orphan drug status for imexon for the treatment of ovarian cancer; a non-prodrug rapamycin analog for the treatment of soft-tissue and bone sarcomas; and an ... / Medscape (subscription)
Hokies' Calloway battling tumor -- Sep 6, 2005
..."This one under the microscope is more like a cluster of grapes surrounded by blood supply. That structure makes it unique among all sarcomas. ... ... / Roanoke Times,
Tech's Calloway battles cancer -- Sep 6, 2005
...rare tumor.". Said Doolan of alveolar soft part sarcoma: "It makes up about .2 to 1 percent of all sarcomas that are out there.". For ... / Lynchburg News and Advance,
Tech basketball player being treated for cancer -- Sep 6, 2005
...basketball trainer Keith Doolan said. "It makes up about .2 to 1 percent of all sarcomas that are out there.". Dr. Delmas Bolin, Tech's ... / Richmond Times Dispatch,
Cancer-Causing Genes Can Convert Even the Most Committed Cells -- Aug 30, 2005
In human connective tissue cancers (called sarcomas), genetic exchange between Chromosomes 21 and 22 produces the EWS-ERG fusion gene; this translocation is ... / RxPG NEWS,
Ariad gets orphan drug status for sarcoma drug -- Aug 18, 2005
Research) on Thursday said the US Food and Drug Administration awarded orphan drug status to its product for the treatment of soft-tissue and bone sarcomas. ... / Reuters
Hot Stocks: JDSU LTD GNLB IDNX HOTT SNPS CRM RITA TINY -2 -- Aug 18, 2005
Said its novel mTOR inhibitor has been designated an orphan drug by the US Food and Drug Administration for the treatment of both soft-tissue and bone sarcomas ... / Yahoo News
Highlights of rising and falling US stocks -- Aug 18, 2005
...its novel mTOR inhibitor, has been designated an orphan drug by the Food and Drug Administration for the treatment of both soft-tissue and bone sarcomas. ... / Investor's Business Daily (subscription)
Ariad receives orphan drug designations -- Aug 18, 2005
...has had AP23573, its novel mTOR inhibitor, designated an orphan drug by the Food and Drug Administration for the treatment of both soft-tissue and bone sarcomas ... / Boston Mass High Tech,
Ariad compound gains FDA 'orphan' status -- Aug 18, 2005
Nasdaq: ARIA) said Thursday that the FDA granted the special status for AP23573, a compound intended to treat soft-tissue and bone cancers known as sarcomas. ... / Boston Business Journal,
Ariad raises $8.1M in stock sale -- Aug 19, 2005
...that it had gained "orphan drug" status from the US Food and Drug Administration for its potential treatment for soft-tissue and bone cancers known as sarcomas ... / Boston Business Journal,
Powders of the Merchant -- Aug 24, 2005
...“Because sarcomas are a very rare tumor, and you have to understand that drug companies, pharmaceutical companies, have to report to their stockholders, and ... / Cape Cod Today,
Ariad Compound Gains FDA 'orphan' Status and Myogen Shares Rise on ... -- Aug 19, 2005
Mass., company said Thursday that the FDA granted the special status for AP23573, a compound intended to treat soft-tissue and bone cancers known as sarcomas. ... / Financial News USA (press release),
10 Things Your Veterinarian Won't Tell You -- Aug 16, 2005
Goldstein, a veterinarian in South Salem, NY, says he sees a range of vaccination-related reactions in animals, everything from cancerous sarcomas to epilepsy. ... / Smartmoney.com (subscription)
Health Stocks in Motion -- Aug 18, 2005
...by the FDA. The inhibitor, designated as AP23573, is used for the treatment of both soft-tissue and bone sarcomas. AP23573, a small ... / TheStreet.com
ALICIA'S STORY -- Aug 17, 2005
...www.sarcomaalliance.org. Sarcoma Foundation of America An advocacy group for increased research on treating and curing sarcomas. www.curesarcoma.org. ... / San Francisco Chronicle,
Soft-Tissue Sarcomas in Adults Aug 17, 2005
Soft-tissue sarcomas are uncommon tumors that have traditionally been managed by wide excisional surgery and radiotherapy; the use of chemotherapy has been ... New England Journal of Medicine (subscription),
FDA Approvals: Amplimexon, AP23573, TQ-1017 Sep 6, 2005
...orphan drug status for imexon for the treatment of ovarian cancer; a non-prodrug rapamycin analog for the treatment of soft-tissue and bone sarcomas; and an ... Medscape (subscription)
Hokies' Calloway battling tumor Sep 6, 2005
..."This one under the microscope is more like a cluster of grapes surrounded by blood supply. That structure makes it unique among all sarcomas. ... ... Roanoke Times,
Tech's Calloway battles cancer Sep 6, 2005
...rare tumor.". Said Doolan of alveolar soft part sarcoma: "It makes up about .2 to 1 percent of all sarcomas that are out there.". For ... Lynchburg News and Advance,
ARIAD Receives Orphan Drug Designations for AP23573 in the ... Aug 18, 2005
...inhibitor, has been designated an orphan drug by the United States Food and Drug Administration (FDA) for the treatment of both soft-tissue and bone sarcomas. ... Business Wire (press release),
Tech basketball player being treated for cancer Sep 6, 2005
...basketball trainer Keith Doolan said. "It makes up about .2 to 1 percent of all sarcomas that are out there.". Dr. Delmas Bolin, Tech's ... Richmond Times Dispatch,
Cancer-Causing Genes Can Convert Even the Most Committed Cells Aug 30, 2005
In human connective tissue cancers (called sarcomas), genetic exchange between Chromosomes 21 and 22 produces the EWS-ERG fusion gene; this translocation is ... RxPG NEWS,
Ariad gets orphan drug status for sarcoma drug Aug 18, 2005
Research) on Thursday said the US Food and Drug Administration awarded orphan drug status to its product for the treatment of soft-tissue and bone sarcomas. ... Reuters
Hot Stocks: JDSU LTD GNLB IDNX HOTT SNPS CRM RITA TINY -2 Aug 18, 2005
Said its novel mTOR inhibitor has been designated an orphan drug by the US Food and Drug Administration for the treatment of both soft-tissue and bone sarcomas ... Yahoo News
Highlights of rising and falling US stocks Aug 18, 2005
...its novel mTOR inhibitor, has been designated an orphan drug by the Food and Drug Administration for the treatment of both soft-tissue and bone sarcomas. ... Investor's Business Daily (subscription)
Ariad receives orphan drug designations Aug 18, 2005
...has had AP23573, its novel mTOR inhibitor, designated an orphan drug by the Food and Drug Administration for the treatment of both soft-tissue and bone sarcomas ... Boston Mass High Tech,
Ariad compound gains FDA 'orphan' status Aug 18, 2005
Nasdaq: ARIA) said Thursday that the FDA granted the special status for AP23573, a compound intended to treat soft-tissue and bone cancers known as sarcomas. ... Boston Business Journal,
Ariad raises $8.1M in stock sale Aug 19, 2005
...that it had gained "orphan drug" status from the US Food and Drug Administration for its potential treatment for soft-tissue and bone cancers known as sarcomas ... Boston Business Journal,
Powders of the Merchant Aug 24, 2005
...“Because sarcomas are a very rare tumor, and you have to understand that drug companies, pharmaceutical companies, have to report to their stockholders, and ... Cape Cod Today,
Ariad Compound Gains FDA 'orphan' Status and Myogen Shares Rise on ... Aug 19, 2005
Mass., company said Thursday that the FDA granted the special status for AP23573, a compound intended to treat soft-tissue and bone cancers known as sarcomas. ... Financial News USA (press release),
10 Things Your Veterinarian Won't Tell You Aug 16, 2005
Goldstein, a veterinarian in South Salem, NY, says he sees a range of vaccination-related reactions in animals, everything from cancerous sarcomas to epilepsy. ... Smartmoney.com (subscription)
Health Stocks in Motion Aug 18, 2005
...by the FDA. The inhibitor, designated as AP23573, is used for the treatment of both soft-tissue and bone sarcomas. AP23573, a small ... TheStreet.com
ALICIA'S STORY Aug 17, 2005
...www.sarcomaalliance.org. Sarcoma Foundation of America An advocacy group for increased research on treating and curing sarcomas. www.curesarcoma.org. ... San Francisco Chronicle,
A quest for answers -- Jun 26, 2005
...on Guam, Spracklen learned of four more cases of leukemia and an additional three cases of other rare childhood cancers, including two sarcomas and one brain ... / Agana Pacific Daily News,
Necessary or not? -- Jun 13, 2005
...vaccination requirement for cats, a lab at the University of Pennsylvania reported a connection between an increase in the number of sarcomas, or cancerous ... / Concord Monitor,
Ask Dr. D. -- Jul 1, 2005
...from a vaccination. Is that true? A. Although quite rare (about one in 10,000 cats) vaccine-associated sarcomas do exist. A lot of ... / Bolton Common,
ARIAD Initiates Phase 2 Clinical Trial of AP23573 in Patients with ... -- Jun 30, 2005
AP23573 has been designated a fast-track product by the US Food and Drug Administration for the treatment of soft-tissue and bone sarcomas. ... / Business Wire (press release),
More Programming Information -- Jun 8, 2005
Sarcomas can be cured but can also be complicated to treat, that's why the University of Miami has an established a sarcoma group. ... / WCSH-TV,
ALICIA'S STORY -- Jun 9, 2005
That there was some "abnormality" in my abdomen. She said a cure for this kind of cancer, and most sarcomas, was to have surgery early. ... / San Francisco Chronicle,
ALICIA'S STORY -- Jun 12, 2005
Sarcomas are a class of rare cancers comprising about 1 percent of new adult cases; they are more common in children. Specific types of sarcoma are even rarer. ... / San Francisco Chronicle,
Catch this early -- Jun 14, 2005
But other cells can become cancerous, such as the myometrium or muscular wall of the uterus. These sarcomas are rare, Carstens said. ... / Press-Enterprise (subscription),
A Recent WHO report, over Two Decades After the Global AIDS ... -- Jun 18, 2005
When in the retroviral business, you detected retroviruses and over the years it had been done in multiple sclerosis, sarcomas and leukemias. ... / Emediawire (press release),
An Elderly Woman With a Non-Healing Ulcer -- Jun 16, 2005
Histologie examination is consistent with squamous cell carcinoma in 95 percent of cases, although basal cell carcinoma, melanoma, and sarcomas also may be ... / RedNova.com,
North Palm Beach cancer survivor bolsters children's cancer ... -- Jun 14, 2005
...synoviosarcoma. "I'm very lucky to be here," said Silvani, now 54. "Sarcomas in general are life-threatening.". Synoviosarcoma invades ... / Jupiter Courier,
Why big pharma needs to learn the three 'R's -- Jun 7, 2005
University, USA, has demonstrated that Viagra can also reduce heart damage in patients on doxorubicin chemotherapy for breast cancer, leukaemia and sarcomas. ... / Nature.com (subscription),
Diagnostic Imaging Update: Soft Tissue Sarcomas -- Feb 10, 2005
...often required. Soft tissue sarcomas require a multimodality approach. Methods ... tissue sarcomas. Soft tissue sarcomas are rare cancers. The ... / Medscape (subscription)
Lucky's Pet Tips -- Mar 9, 2005
Dr. Edward Levine, a surgical oncologist at Wake Forest University Baptist Medical Center says, "What separates sarcomas from carcinomas which are malignant ... / WFMY News 2,
Two-dimensional and 3-dimensional optical coherence tomographic ... -- Mar 4, 2005
METHODS: Freshly excised lungs and pleural tissue obtained from rabbits with inhalation lung injury and induced empyema, metastatic sarcomas, and pleural ... / The Journal of Thoracic and Cardiovascular Surgery
O'Shea banking on Falkirk to end the pain -- Mar 4, 2005
She was a carnival horse. Respected veterinarian Greg Nash reckons sarcomas are rarely found in horses, they are all but unheard of in thoroughbreds. ... / Sydney Morning Herald (subscription),
Dioxin: Common Questions and Answers -- Mar 9, 2005
...cancers. Some studies suggest that it promotes lung cancer and soft-tissue sarcomas, which are cancers of the fat and muscle. Most ... / Biloxi Sun Herald,
Keratin-Positive Ewing's Sarcoma: An Ultrastructural Study of 12 ... -- Feb 26, 2005
For instance, biphenotypic sarcomas displaying both myogenic and neural differentiation and the EWS/FLI-1 fusion transcript have also been reported [22,23]. ... / RedNova.com,
BU names new head of medical school -- Feb 15, 2005
A cancer specialist noted for her work on bone marrow transplants and sarcomas, Antman was on the faculty of Harvard Medical School from 1979 to 1993. ... / Boston Globe
New European body for cancer research -- Mar 1, 2005
France, the Netherlands and Germany, as well as two US universities, ECRIS will study tumour sites in pancreatic cancer, rectal cancer, sarcomas, lung cancer ... / Cordis News,
Intraop Medical Inc. Announces Major European Cancer Centers Form ... -- Feb 28, 2005
Among the tumor sites that are expected to be studied by ECRIS are pancreatic cancer, rectal cancer, sarcomas, lung cancer, breast cancer, prostate cancer, and ... / Business Wire (press release),
Pro-Pharmaceuticals Engages WorldCare Clinical to Enhance and ... -- Feb 24, 2005
...his fourteen years in clinical practice, he specialized in the treatment of breast cancer, malignant melanoma, gastrointestinal tumors and soft part sarcomas. ... / Business Wire (press release),
Targeting tumors: New technology takes out the bad but doesn't ... -- Feb 25, 2005
..."We've treated both benign and cancerous tumors of the spine, brain, head, neck, lung, liver, and pancreas, and sarcomas," said Andrea Pointer, RN, and ... / Kansas City Nursing News,
Newly identified gene cluster on mouse X chromosome provides ... -- Feb 10, 2005
...normally restricted in expression to reproductive tissues, is aberrantly expressed in a wide variety of tumors, including carcinomas, sarcomas and lymphomas. ... / Medical News Today,
In the spotlight of cancer care -- Feb 13, 2005
...of the brain and central nervous system, gastrointestinal cancer, head and neck cancer, lung cancer, lymphomas and leukaemia, sarcomas, gynaecological cancer ... / Cyprus Mail,
A sarcoma is a cancer of the bone, cartilage, fat, muscle, blood vessels, or other connective or supportive tissue.
The term comes from a Greek word meaning "fleshy growth." Bone tumors (osteosarcomas) are also called sarcomas, but are in a separate category because they have different clinical and microscopic characteristics and are treated differently. Osteogenic sarcoma or osteosarcoma is one of the most common childhood bone cancers.
Organizations such as the Sarcoma Foundation of America are working to fund research towards a cure for sarcoma, while other patient-oriented organizations such as the Sarcoma Alliance are working to educate patients about the disease, and still others like the Rare Cancer Alliance are working to give patients online support.
The most famous victim of this disease is Terry Fox who was required to have a leg amputated as treatment. He subsesquently began heroic fundraising efforts towards medical research which enabled advances that dramatically improved the survivability of the ailment.
|
|
|
